Pulse therapy may be just as good as daily pills for Kids' scalp fungus
NCT ID NCT07184203
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study compares two treatment schedules for oral itraconazole in children aged 5 to 18 with tinea capitis (scalp ringworm). One group takes the drug daily, the other takes it in pulses (intermittent doses). Researchers will check cure rates using clinical exams, lab tests, and dermoscopy. The goal is to find out if pulse therapy works as well as daily therapy, potentially reducing side effects and improving convenience.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Itraconazole (oral antifungal drug)
- What this could lead to
- If successful, this could show that pulse therapy works as well as daily therapy, making treatment easier and safer for children.
- What could go wrong
- This is a small, early-phase study with only 120 participants. Results may not apply to all children, and itraconazole can cause side effects like liver issues or stomach upset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TINEA CAPITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine
RECRUITINGAlexandria, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.